ORGANOGENESIS HOLDINGS INC. Financing Cash Flow
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Financing Cash Flow of -$32.72 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$12.50M.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$20.21M.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$4.81M, a 114.29% decline year-over-year.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$10.21M.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) financing activities for fiscal 2025 was -$17.36M, a 162.81% decline from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) financing activities for fiscal 2024 was $27.64M.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) financing activities for fiscal 2023 was -$5.50M.
- ORGANOGENESIS HOLDINGS INC. net cash provided by (used in) financing activities for fiscal 2022 was -$2.20M.
| Period end | Net Cash Provided by (Used in) Financing Activities 1 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$12.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$32.72M 10-Q · filed 2026-08-06 | -$37.52M derived: sum of 3 quarters · filed 2026-08-06 | -$47.73M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2026-03-31 | -$20.21M 10-Q · filed 2026-05-07 | -$25.02M derived: sum of 2 quarters · filed 2026-05-07 | -$35.23M derived: sum of 3 quarters · filed 2026-05-07 | -$35.52M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-12-31 | -$4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$15.02M derived: sum of 2 quarters · filed 2026-02-26 | -$15.30M derived: sum of 3 quarters · filed 2026-08-06 | -$17.36M 10-K · filed 2026-02-26 | |||||
| 2025-09-30 | -$10.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$10.49M derived: sum of 2 quarters · filed 2026-08-06 | -$12.55M 10-Q · filed 2025-11-06 | $21.10M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-06-30 | -$288.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.34M 10-Q · filed 2026-08-06 | $31.30M derived: sum of 3 quarters · filed 2026-08-06 | $29.63M derived: sum of 4 quarters · filed 2026-08-06 | |||||
| 2025-03-31 | -$2.06M 10-Q · filed 2026-05-07 | $31.59M derived: sum of 2 quarters · filed 2026-05-07 | $29.92M derived: sum of 3 quarters · filed 2026-05-07 | $28.19M derived: sum of 4 quarters · filed 2026-05-07 | |||||
| 2024-12-31 | $33.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $31.97M derived: sum of 2 quarters · filed 2026-02-26 | $30.25M derived: sum of 3 quarters · filed 2026-02-26 | $27.64M 10-K · filed 2026-02-26 | |||||
| 2024-09-30 | -$1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$3.40M derived: sum of 2 quarters · filed 2025-11-06 | -$6.01M 10-Q · filed 2025-11-06 | -$7.79M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2024-06-30 | -$1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$4.33M 10-Q · filed 2025-08-07 | -$6.11M derived: sum of 3 quarters · filed 2026-02-26 | -$7.55M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2024-03-31 | -$2.61M 10-Q · filed 2025-05-08 | -$4.38M derived: sum of 2 quarters · filed 2026-02-26 | -$5.82M derived: sum of 3 quarters · filed 2026-02-26 | -$6.88M derived: sum of 4 quarters · filed 2026-02-26 | |||||
| 2023-12-31 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$3.21M derived: sum of 2 quarters · filed 2026-02-26 | -$4.27M derived: sum of 3 quarters · filed 2026-02-26 | -$5.50M 10-K · filed 2026-02-26 | |||||
| 2023-09-30 | -$1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$2.49M derived: sum of 2 quarters · filed 2024-11-12 | -$3.73M 10-Q · filed 2024-11-12 | -$5.60M derived: sum of 4 quarters · filed 2025-02-27 | |||||
| 2023-06-30 | -$1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$2.29M 10-Q · filed 2024-08-08 | -$4.17M derived: sum of 3 quarters · filed 2025-02-27 | -$4.14M derived: sum of 4 quarters · filed 2025-02-27 | |||||
| 2023-03-31 | -$1.24M 10-Q · filed 2024-05-09 | -$3.11M derived: sum of 2 quarters · filed 2025-02-27 | -$3.08M derived: sum of 3 quarters · filed 2025-02-27 | -$2.67M derived: sum of 4 quarters · filed 2025-02-27 | |||||
| 2022-12-31 | -$1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.85M derived: sum of 2 quarters · filed 2025-02-27 | -$1.43M derived: sum of 3 quarters · filed 2025-02-27 | -$2.20M 10-K · filed 2025-02-27 | |||||
| 2022-09-30 | $26.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $441.00K derived: sum of 2 quarters · filed 2023-11-09 | -$324.00K 10-Q · filed 2023-11-09 | -$1.24M derived: sum of 4 quarters · filed 2024-02-29 | |||||
| 2022-06-30 | $415.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$350.00K 10-Q · filed 2023-08-09 | -$1.27M derived: sum of 3 quarters · filed 2024-02-29 | $3.00K derived: sum of 4 quarters · filed 2024-02-29 | |||||
| 2022-03-31 | -$765.00K 10-Q · filed 2023-05-10 | -$1.68M derived: sum of 2 quarters · filed 2024-02-29 | -$412.00K derived: sum of 3 quarters · filed 2024-02-29 | -$1.21M derived: sum of 4 quarters · filed 2024-02-29 | |||||
| 2021-12-31 | -$917.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $353.00K derived: sum of 2 quarters · filed 2024-02-29 | -$445.00K derived: sum of 3 quarters · filed 2024-02-29 | -$1.04M 10-K · filed 2024-02-29 | |||||
| 2021-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $472.00K derived: sum of 2 quarters · filed 2022-11-09 | -$119.00K 10-Q · filed 2022-11-09 | $30.00M derived: sum of 4 quarters · filed 2023-03-01 | |||||
| 2021-06-30 | -$798.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$1.39M 10-Q · filed 2022-08-09 | $28.73M derived: sum of 3 quarters · filed 2023-03-01 | $27.96M derived: sum of 4 quarters · filed 2023-03-01 | |||||
| 2021-03-31 | -$591.00K 10-Q · filed 2022-05-10 | $29.53M derived: sum of 2 quarters · filed 2023-03-01 | $28.76M derived: sum of 3 quarters · filed 2023-03-01 | $33.65M derived: sum of 4 quarters · filed 2023-03-01 | |||||
| 2020-12-31 | $30.12M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $29.35M derived: sum of 2 quarters · filed 2023-03-01 | $34.24M derived: sum of 3 quarters · filed 2023-03-01 | $42.47M 10-K · filed 2023-03-01 | |||||
| 2020-09-30 | -$775.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $4.12M derived: sum of 2 quarters · filed 2021-11-09 | $12.35M 10-Q · filed 2021-11-09 | $59.41M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2020-06-30 | $4.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $13.12M 10-Q · filed 2021-08-09 | $60.19M derived: sum of 3 quarters · filed 2022-03-01 | $69.92M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2020-03-31 | $8.23M 10-Q · filed 2021-05-11 | $55.30M derived: sum of 2 quarters · filed 2022-03-01 | $65.03M derived: sum of 3 quarters · filed 2022-03-01 | $67.82M derived: sum of 4 quarters · filed 2022-03-01 | |||||
| 2019-12-31 | $47.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $56.80M derived: sum of 2 quarters · filed 2022-03-01 | $59.59M derived: sum of 3 quarters · filed 2022-03-01 | $78.73M 10-K · filed 2022-03-01 | |||||
| 2019-09-30 | $9.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $12.52M derived: sum of 2 quarters · filed 2020-11-09 | $31.66M 10-Q · filed 2020-11-09 | $44.94M derived: sum of 4 quarters · filed 2021-03-16 | |||||
| 2019-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $21.93M 10-Q · filed 2020-08-10 | $35.21M derived: sum of 3 quarters · filed 2021-03-16 | $83.72M derived: sum of 4 quarters · filed 2021-03-16 | |||||
| 2019-03-31 | $19.13M 10-Q · filed 2020-05-11 | $32.42M derived: sum of 2 quarters · filed 2021-03-16 | $80.92M derived: sum of 3 quarters · filed 2021-03-16 | $97.59M derived: sum of 4 quarters · filed 2021-03-16 | |||||
| 2018-12-31 | $13.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $61.79M derived: sum of 2 quarters · filed 2021-03-16 | $78.46M derived: sum of 3 quarters · filed 2021-03-16 | $81.54M 10-K · filed 2021-03-16 | $81.64M 10-K · filed 2019-03-18 | ||||
| 2018-09-30 | $48.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $65.17M derived: sum of 2 quarters · filed 2019-11-12 | $68.25M 10-Q · filed 2019-11-12 | $600.00K 10-Q · filed 2018-11-09 | $87.55M derived: sum of 4 quarters · filed 2020-03-09 | ||||
| 2018-06-30 | $16.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $19.75M 10-Q · filed 2019-08-09 | $375.00K 10-Q · filed 2018-08-07 | $39.04M derived: sum of 3 quarters · filed 2020-03-09 | $39.04M derived: sum of 4 quarters · filed 2020-03-09 | ||||
| 2018-03-31 | $3.08M 10-Q · filed 2019-05-10 | $200.00K 10-Q · filed 2018-05-10 | $22.38M derived: sum of 2 quarters · filed 2020-03-09 | $22.38M derived: sum of 3 quarters · filed 2020-03-09 | $22.38M derived: sum of 4 quarters · filed 2020-03-09 | ||||
| 2017-12-31 | $19.29M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | $19.29M derived: sum of 2 quarters · filed 2020-03-09 | $19.29M derived: sum of 3 quarters · filed 2020-03-09 | $18.87M 10-K · filed 2020-03-09 | -$327.58K 10-K · filed 2018-03-14 | ||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-11-09 | -$427.58K 10-Q · filed 2018-11-09 | $6.28M derived: sum of 4 quarters · filed 2019-03-18 | |||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$427.58K 10-Q · filed 2018-08-07 | $6.28M derived: sum of 3 quarters · filed 2019-03-18 | $6.37M derived: sum of 4 quarters · filed 2019-03-18 | |||||
| 2017-03-31 | -$427.58K 10-Q · filed 2018-05-10 | $6.28M derived: sum of 2 quarters · filed 2019-03-18 | $6.37M derived: sum of 3 quarters · filed 2019-03-18 | ||||||
| 2016-12-31 | $6.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $6.80M derived: sum of 2 quarters · filed 2019-03-18 | $6.78M 10-K · filed 2019-03-18 | $311.48M 10-K · filed 2018-03-14 | |||||
| 2016-09-30 | $90.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $70.26K 10-Q · filed 2017-11-14 | |||||||
| 2016-06-30 | -$20.00K 10-Q · filed 2017-08-11 | ||||||||
| 2015-12-31 | $142.75K 10-K · filed 2018-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |